[Combination therapy for hypertension]

Anton H van den Meiracker1, A H J Jan Danser

  • 1Erasmus MC, afd. Inwendige Geneeskunde, Rotterdam.

Insights

Antihypertensive monotherapy has limited blood pressure reduction. Combination therapy with multiple agents is often needed for effective hypertension management, especially using renin-angiotensin-system blockers with other drug classes.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Antihypertensive monotherapy offers limited blood pressure reduction, with average systolic lowering of 9.1 mmHg and diastolic of 5.5 mmHg.
  • Approximately two-thirds of the hypertensive population require two or more antihypertensive agents for adequate control.

Purpose of the Study:

  • To review the rationale and strategies for initiating combination antihypertensive therapy.
  • To emphasize the importance of combination therapy for achieving blood pressure targets and improving patient compliance.

Main Methods:

  • Literature review on the efficacy and mechanisms of antihypertensive drug combinations.
  • Analysis of treatment initiation strategies, including stepwise versus immediate combination therapy.

Main Results:

  • Combination therapy, particularly with a renin-angiotensin-system (RAS) blocking agent and a RAS-independent agent, is recommended due to complementary mechanisms and proven efficacy.
  • Initial treatment may involve a stepwise approach or immediate initiation of two agents if blood pressure is significantly elevated (>20/10 mmHg).

Conclusions:

  • Combination antihypertensive therapy is essential for a majority of hypertensive patients.
  • Fixed-dose combination preparations are preferred to improve treatment compliance and adherence.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
1.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
642
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
691
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
891